BG-12 Pill Shows Promise in Suppressing Multiple Sclerosis Relapses
[unable to retrieve full-text content]Clinical trials indicate that BG-12, developed by Biogen Idec, may be safer and more effective than existing treatments for patients in the early stages of the disease.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.